🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a multicentre, open-label, phase II study of ibrutinib 560 mg in co...
Status
Unknown
Location
National University Hospital Singapore
Start Date
2016-12-13
Trial ID
NCT02955628
Treatments Being Tested
This is an open-label, single-arm, multicenter, Phase 1/2 study evaluating ...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham
Start Date
2022-08-30
Trial ID
NCT05456880
Treatments Being Tested
Based on the further need to improve progression-free survival (PFS) and ov...
Status
Completed
Location
Washington University School of Medicine
Start Date
2017-08-01
Trial ID
NCT03072771
PET-based consolidation and donor-based therapy after rescue in patients wi...
Status
Terminated
Location
Istituto di Ematologia e Oncologia Medica, Policlinico S. Orsola
Start Date
2009-05
Trial ID
NCT00879528
Phase II study is being conducted to confirm the safety and efficacy of hig...
Status
Completed
Location
Washington University School of Medicine
Start Date
2014-03-19
Trial ID
NCT01969435
Treatments Being Tested
High-dose chemotherapy and autologous stem-cell transplantation have an est...
Status
Unknown
Location
Soroka Universuty Medical Center
Start Date
2007-04
Trial ID
NCT00463463
Treatments Being Tested
The purpose of the study is to evaluate the efficacy of an intensified firs...
Status
Completed
Location
AO Spedali Civili di Brescia
Start Date
2007-01
Trial ID
NCT01045889
Treatments Being Tested
The purpose of this study is to evaluate validation and clinical assessment...
Status
Unknown
Location
Lithuanian University of Health Sciences
Start Date
2014-02
Trial ID
NCT02054676
The purpose of this study is to determine the correct dose and safety of ad...
Status
Completed
Location
University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center
Start Date
2019-03-12
Trial ID
NCT03713580
Treatments Being Tested